Browse > Article
http://dx.doi.org/10.5808/GI.2009.7.4.195

Lack of Association of BIRC5 Polymorphisms with Clearance of HBV Infection and HCC Occurrence in a Korean Population  

Lee, Jin-Sol (Department of Life Science, Sogang University)
Kim, Jeong-Hyun (Department of Life Science, Sogang University)
Park, Byung-Lae (Department of Genetic Epidemiology, SNP Genetics, Inc.)
Cheong, Hyun-Sub (Department of Genetic Epidemiology, SNP Genetics, Inc.)
Kim, Jason-Y. (Department of Life Science, Sogang University)
Park, Tae-Joon (Department of Life Science, Sogang University)
Chun, Ji-Yong (Department of Life Science, Sogang University)
Bae, Joon-Seol (Department of Life Science, Sogang University)
Lee, Hyo-Suk (Department of Internal Medicine and Liver Research Institute, Seoul National University)
Kim, Yoon-Jun (Department of Internal Medicine and Liver Research Institute, Seoul National University)
Shin, Hyoung-Doo (Department of Life Science, Sogang University)
Publication Information
Genomics & Informatics / v.7, no.4, 2009 , pp. 195-202 More about this Journal
Abstract
BIRC5 (Survivin) belongs to the inhibitor of apoptosis gene family. The BIRC5 protein inhibits caspases and consequently blocks apoptosis. Thus, BIRC5 contributes to the progression of cancer allowing for continued cell proliferation and survival. In this study, we identified eight sequence variants of BIRC5 through direct DNA sequencing. Among the eight single nucleotide polymorphisms (SNPs), six common variants with frequencies higher than 0.05 were selected for larger-scale genotyping (n=1,066). Results of the study did not show any association between the promoter region polymorphisms and the clearance of hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) occurrence. This is in line with a previous study in which polymorphisms in the promoter region does not influence the function of BIRC5. Initially, we were able to detect a signal with the ＋9194A>G, which disappeared after multiple corrections but led to a change in amino acid. Similarly, we were also able to detect an association signal between two haplotypes (haplotype-2 and haplotype-5) on the onset age of HCC and/or HCC occurrence, but the signals also disappeared after multiple corrections. As a result, we concluded that there was no association between BIRC5 polymorphisms and the clearance HBV infection and/or HCC occurrence. However, our results might useful to future studies.
Keywords
BIRC5; survivin; hepatitis B virus (HBV); hepatocellular carcinoma (HCC); liver cirrhosis (LC); polymorphism;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Altieri, D.C. (2003). Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3, 46-54   DOI   PUBMED   ScienceOn
2 Ambrosini, G., Adida, C., Sirugo, G., and Altieri, D.C. (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem . 273, 11177-11182   DOI   ScienceOn
3 Kida, A., Kakihana, K., Kotani, S., Kurosu, T., and Miura, O. (2007). Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene 26, 6630-6640   DOI   ScienceOn
4 Lok, A.S., and McMahon, B.J. (2007). Chronic hepatitis B. Hepatology 45, 507-539   DOI   ScienceOn
5 Montorsi, M., Maggioni, M., Falleni, M., Pellegrini, C., Donadon, M., Torzilli, G., Santambrogio, R., Spinelli, A., Coggi, G., and Bosari, S. (2007). Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Hepatogastroenterology 54, 2040-2044   PUBMED
6 Wang, Y.H., Chiou, H.Y., Lin C.T., Hsieh, H.Y., Wu, C.C., Hsu, C.D., and Shen, C.H. (2009). Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73, 670-674   DOI   ScienceOn
7 Stephens, M., Smith, N.J., and Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet . 68, 978-989   DOI   ScienceOn
8 Altieri, D.C. (1994a). Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J. Biol. Chem . 269, 3139-3142   PUBMED
9 Park, B.L., Kim, Y.J., Cheong, H.S., Kim L.H., Choi, Y.H., Lee, H.S., and Shin, H.D. (2006). Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance. Exp. Mol. Med . 38, 694-702   DOI   ScienceOn
10 Menashe, I., Rosenberg, P.S., and Bingshu, E.C. (2008). PGA: power calculator for case-control genetic association analyses. BMC Genet. 9, 36   DOI   PUBMED   ScienceOn
11 Lin, C.L., and Kao, J.H. (2008). Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J. Biomed. Sci . 15, 137-145   DOI   ScienceOn
12 Yang, L., Zhu, H., Zhou, B., Gu, H., Yan, H., Tang, N., Dong, H., Sun, Q., Cong, R., Chen, G., and Wang, B. (2009). The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig. Dis. Sci. 54, 1021-1028   DOI   ScienceOn
13 Castedo, M., Perfettini, J.L., Roumier, T., Andreau, K., Medema, R.H., and Kroemer, G. (2004). Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825-2837   DOI   ScienceOn
14 Boidot, R., Vegran, F., Jacob, D., Chevrier, S., Gangneux, N., Taboureau, J., Oudin, C., Rainville, V., Mercier, L., and Lizard-Nacol, S. (2008). The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas. Genes Chromosomes Cancer 47, 299-308   DOI   ScienceOn
15 Kim, Y.J., Yoon, J.H., Kim, C.Y., Kim, L.H., Park, B.L., Shin, H.D., and Lee, H.S. (2006). IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem. Biophys. Res. Commun . 346, 38-44   DOI   ScienceOn
16 Shin, H.D., Park, B.L., Kim, L.H., Jung, J.H., Kim, J.Y., Yoon, J.H., Kim, Y,J., and Lee, H.S. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 12, 901-906   DOI   ScienceOn
17 Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J.C. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. Embo. J . 22, 2729-2740   DOI   ScienceOn
18 Merican, I., Guan, R., Amarapuka, D., Alexander, M.J., Chutaputti, A., Chien, R.N., Hasnian, S.S., Leung, N., Lesmana, L., Phiet, P.H., Sjalfoellah Noer, H.M., Sollano, J., Sun, H.S., and Xu, D.Z. (2000). Chronic hepatitis B virus infection in Asian countries. J. Gastroenterol. Hepatol . 15, 1356-1361   DOI   ScienceOn
19 Jang, J.S., Kim, K.M., Kang, K.H., Choi, J.E., Lee, W.K., Kim, C.H., Kang, Y.M., Kam, S., Kim, I.S., Jun, J.E., Jung, T.H., and Park, J.Y. (2008). Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60, 31-39   DOI   ScienceOn
20 Sah, N.K., Khan, Z., Khan, G., and Bisen, P. (2006). Structural, functional and therapeutic biology of survivin. Cancer Lett. 244, 164-171   DOI   ScienceOn
21 Altieri, D.C. (1994b). Splicing of effector cell protease receptor- 1 mRNA is modulated by an unusual retained intron. Biochemistry 33, 13848-13855   DOI   PUBMED   ScienceOn
22 An, P., Nelson, G.W., Wang, L., Donfield, S., Goedert, J.J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W.L., Modi, W., O'Brien, S.J., and Winkler C.A. (2002). Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. USA 99, 10002-10007   DOI   ScienceOn
23 Hedrick, P.W. (1987). Gametic disequilibrium measures: proceed with caution. Genetics 117, 331-341   PUBMED
24 Lee, M.S., Kim, D.H., Kim, H., Lee, H.S., Kim, C.Y., Park, T.S., Yoo, K.Y., Park, B.J., and Ahn Y.O. (1998). Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int. J. Epidemiol . 27, 316-319   DOI   ScienceOn